MOHAMMAD ZUBAIR

Prof. Dr. MOHAMMAD ZUBAIR

MEDICAL MICROBIOLOGY, Faculty of Medicine, University of Tabuk, Tabūk, Saudi Arabia
orcid
Professor of Medical Microbiology

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
SNSaba Noor
Saba Noor
MZMOHAMMAD ZUBAIR
MOHAMMAD ZUBAIR
JAJamal Ahmad
Jamal Ahmad

1 April 2019 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
MZMOHAMMAD ZUBAIR
MOHAMMAD ZUBAIR
JAJamal Ahmad
Jamal Ahmad

1 March 2011 in The Foot
Verified
Journal Article
Closed access
MZMOHAMMAD ZUBAIR
MOHAMMAD ZUBAIR
AMAbida Malik
Abida Malik
JAJamal Ahmad
Jamal Ahmad

29 July 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
Asghar AliAsghar Ali
Asghar Ali
AZAndaleeb Zahra
Andaleeb Zahra
MKMohan Kamthan
Mohan Kamthan
FHFohad Mabood Husain
Fohad Mabood Husain
TAThamer Albalawi
Thamer Albalawi
MNMd Salik Noorani
Md Salik Noorani
Biofilms are complex communities of microorganisms that grow on surfaces and are embedded in a matrix of extracellular polymeric substances. These are prevalent in various natural and man-made environments, ranging from industrial settings to medical devices, where they can have both positive and negative impacts. This review explores the diverse applications of microbial biofilms, their clinical consequences, and alternative therapies targeting these resilient structures. We have discussed beneficial applications of microbial biofilms, including their role in wastewater treatment, bioremediation, food industries, agriculture, and biotechnology. Additionally, we have highlighted the mechanisms of biofilm formation and clinical consequences of biofilms in the context of human health. We have also focused on the association of biofilms with antibiotic resistance, chronic infections, and medical device-related infections. To overcome these challenges, alternative therapeutic strategies are explored. The review examines the potential of various antimicrobial agents, such as antimicrobial peptides, quorum-sensing inhibitors, phytoextracts, and nanoparticles, in targeting biofilms. Furthermore, we highlight the future directions for research in this area and the potential of phytotherapy for the prevention and treatment of biofilm-related infections in clinical settings.

1 July 2013 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MZMOHAMMAD ZUBAIR
MOHAMMAD ZUBAIR
AMAbida Malik
Abida Malik
DMDilnasheen Meerza
Dilnasheen Meerza
JAJamal Ahmad
Jamal Ahmad

1 April 2013 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
AMAbida Malik
Abida Malik
MZMOHAMMAD ZUBAIR
MOHAMMAD ZUBAIR
JAJamal Ahmad
Jamal Ahmad